Hemolytic Transfusion Reactions Caused by Failure of Commercial Antiglobulin Reagents To Detect Complement
- 10 September 1976
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 16 (5) , 417-420
- https://doi.org/10.1046/j.1537-2995.1976.16577039295.x
Abstract
Two definite acute hemolytic transfusion reactions occurred in a patient with chronic myelogenous leukemia in blastic crisis. Both suspect units were entirely compatible by routine crossmatch using commercial antiglobulin sera. However, both units were clearly incompatible using our own specific anti-C3 antiserum in the antiglobulin reaction phase of the crossmatch. Subsequently it was possible to predict in vivo compatibility using our anti-C3 antiserum in vitro. This case adds new evidence for the inadequacy of anticomplement activity in commercial antisera.This publication has 5 references indexed in Scilit:
- Evaluation of Commercial Antiglobulin Sera Over a Two‐ Year Period. Part I. Anti‐Beta 1A, Anti‐Alpha 2D, and Anti‐Beta IE LevelsTransfusion, 1974
- Measurement of the Third Component of Complement Bound to Red Blood Cells in Patients with the Cold Agglutinin SyndromeJournal of Clinical Investigation, 1973
- An Evaluation of Commercial Antiglobulin Sera with Particular Reference to Their Anticomplement PropertiesTransfusion, 1971
- Erythrocyte coating substances in patients with positive direct antiglobulin reactionsThe American Journal of Medicine, 1969
- ‘Incomplete’ Cold Antibodies: Role of Complement in Sensitization to Antiglobulin Serum by Potentially Haemolytic AntibodiesBritish Journal of Haematology, 1957